TENXTenax Therapeutics, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 22432
Ticker: TENX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1995-02-01
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TENX

Detail

Enriched 2026-08-14 20:47

Market cap: $64,369,137.24
Shares outstanding (class): 37,423,917
Shares outstanding (weighted): 37,423,917
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 16
Location: CHAPEL HILL, NC
Homepage: https://www.tenaxthera.com
Description: Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Market cap and share counts drift.

Funds holding this security

10 funds · 10 positions · $47.11M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$39.67M	0.36%	2,481,066 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$3.10M	0.00%	194,159 NS	FIGI
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC.	—	$2.42M	0.37%	151,450 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$1.03M	0.00%	64,186 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$718.0K	0.84%	44,900 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$81.2K	0.00%	5,076 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$26.3K	0.00%	1,644 NS	FIGI
T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc.	TNXT	$24.2K	0.16%	1,516 NS	FIGI
Health Sciences Trust John Hancock Variable Insurance Trust	—	$19.2K	0.01%	1,202 NS	FIGI
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust	—	$13.5K	0.01%	842 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERTENX
FIGI_COMPOSITEBBG000BJ6R36
FIGI_SHARE_CLASSBBG001S78GM3
CIK0000034956
ISINUS88032L6056
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Tenax Therapeutics is a pharmaceutical company developing treatments for cardiovascular and pulmonary diseases, matching the SIC code for pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.